Month: January 2015

IPO Week Ahead Schedule: Week of February 2nd

Week of Feb. 2nd Eyegate Pharmaceuticals (Nasdaq: EYEG) Wednesday AltheaDx, Inc (Nasdaq: IDGX) Infraredx (Nasdaq: REDX) Carbylan Therapeutics (Nasdaq: CBYL) Thursday Asante Solutions, Inc. (Nasdaq: PUMP) Inotek Pharmaceuticals Corporation (Nasdaq: ITEK) Nexvet Biopharma plc (Nasdaq: NVET) Advanced Accelerator Applications S.A. (Nasdaq: AAAP) Friday Check-Cap Ltd (Nasdaq: CHEK) Columbia Pipeline Partners LP (NYSE: CPPL) Easterly Government[…]

IPO Pricings 1.29.2015

Shake Shack (NYSE: SHAK) — Shake Shack prices deal above range. Shake Shack prices 5 million shares at $21 and will debut on Friday. Spark Therapeutics (Nasdaq: ONCE) — Spark Therapeutics upsizes IPO and prices above range. Spark prices 7 million shares at $23.00 and will debut on Friday. The revised range was 6.5 million[…]

Secondaries Announced 1.29.2015

IPOBoutique.Com rates secondary offerings to hit the tape with a ‘BUY’, ‘NEUTRAL’ or ‘AVOID’ rating. Senior Managing Partner Scott Sweet maintains a track record for all secondary’s he’s issued with a ‘BUY’ rating. To subscribe to his secondary ratings, click here. Company: K2M Group Holdings

IPO Pricing 1.28.2015

Flex Pharma (Nasdaq: FLKS) – Flex Pharma upsizes and prices deal above range. Flex prices 5.4 million shares at $16.00. The initial filing stated that they would offer 4.6 million shares at a range of $12-$14. Entellus Medical (Nasdaq: ENTL) – Entellus Medical upsizes IPO and prices at top end of range. The deal was[…]

Secondary’s Announced 1.28.2015

IPOBoutique.Com rates secondary offerings to hit the tape with a ‘BUY’, ‘NEUTRAL’ or ‘AVOID’ rating. Senior Managing Partner Scott Sweet maintains a track record for all secondary’s he’s issued with a ‘BUY’ rating. To subscribe to his secondary ratings, click here. Company: Omeros

Secondary’s Announced 1.27.2015

IPOBoutique.Com rates secondary offerings to hit the tape with a ‘BUY’, ‘NEUTRAL’ or ‘AVOID’ rating. Senior Managing Partner Scott Sweet maintains a track record for all secondary’s he’s issued with a ‘BUY’ rating. To subscribe to his secondary ratings, click here. Company: Synergy Resources

Secondaries announced 1.26.2015

IPOBoutique.Com rates secondary offerings to hit the tape with a ‘BUY’, ‘NEUTRAL’ or ‘AVOID’ rating. Senior Managing Partner Scott Sweet maintains a track record for all secondary’s he’s issued with a ‘BUY’ rating. To subscribe to his secondary ratings, click here. Company: Post Holding

IPOs Week Ahead: Week of 1.26.2015

Tuesday Zosano Pharma (Nasdaq: ZSAN) Wednesday Presbia PLC (Nasdaq: LENS) Thursday Ascendis Pharma A/S (Nasdaq: ASND) Entellus Medical (Nasdaq: ENTL) Flex Pharma (Nasdaq: FLKS) Friday Avinger (Nasdaq: AVGR) Infraredx (Nasdaq: REDX) InfraREIT (NYSE: HIFR) Shake Shack (NYSE: SHAK) Spark Therapeutics (Nasdaq: ONCE) Tracon Pharmaceuticals (Nasdaq: TCON) Subscribe now to get our full research report, IPO[…]

IPO Weekly Recap: Box shines in debut

This past week one IPO debuted, twelve updated terms and one new deal filed. A highly anticipated deal, Box Inc. (NYSE: BOX), came to market on Friday after pricing $1 above the range ($14). ‘BOX’ opened 44% higher with a $20.20 print at first trade. Box fared even better in the aftermarket as the deal[…]

IPOBoutique Brief: Box IPO Primer

Last night, Box, Inc. (NYSE: BOX) priced its IPO $1 above the $11-$13 range at $14. The deal was 12.5 million shares and raised $175 million for the company. Box was the subject of a lot of media speculation this week. Box was valued at $2.4 billion during its last round of funding yet is[…]

Secondaries announced 1.21.2015

Company: Radius Health, Inc. Symbol: RDUS Price: Last trade $39.37 Trade Date: 1/23 Shares: 3.5 million Underwriter(s) Goldman Sachs, BofA Merrill Lynch, Cowen & Co. Rating=Subscribe for Rating Company: Zafgen, Inc. Symbol: ZFGN Price: Last trade $34.79 Trade Date: 1/22 Shares: 2.84 million Underwriter(s) Leerink Partners, Cowen & Co. Co Manager(s) Canaccord Genuity, JMP Securities[…]

IPOBoutique Brief: 1.20.2015 — Flood of IPOs set terms

We expected 2015 to be a robust year for IPOs and were somewhat surprised that more deals did not come to market or set terms before MLK Day.  However, that surprise was greeted with eight companies releasing official filings to the SEC setting terms for their respective IPOs. Avinger (Nasdaq: AVGR) – Trade Date: Week[…]

Scroll to top
error: Content is protected !!